Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Medical Nanotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran.
Biomed Pharmacother. 2021 Jul;139:111553. doi: 10.1016/j.biopha.2021.111553. Epub 2021 Apr 10.
miR-379 is a miRNA transcribed from the MIR379 locus on 14q32.31. This miRNA is located in an evolutionarily conserved miRNA cluster in an imprinted region that contains DLK1 and DIO3 genes. The mouse homolog of this miRNA has been shown to be under-expressed in response to glucocorticoid receptor deficiency. Moreover, miR-379 has a tumor-suppressive role in a wide variety of tissues including the brain, breast, lung, and liver. In addition to restraining cell proliferation and migration, miR-379 can suppress the epithelial-mesenchymal transition process. Abnormal expression of this miRNA implies the pathogenesis of Duchene muscular dystrophy, spinal cord injury, diabetic nephropathy, acute myocardial infarction, and premature ovarian failure. This review aims to the summarization of the role of miR-379 in neoplastic and non-neoplastic conditions.
miR-379 是一种由 14q32.31 上的 MIR379 基因座转录的 miRNA。该 miRNA 位于印记区域中一个进化上保守的 miRNA 簇内,该簇包含 DLK1 和 DIO3 基因。该 miRNA 的小鼠同源物已被证明在糖皮质激素受体缺乏时表达下调。此外,miR-379 在多种组织中具有肿瘤抑制作用,包括脑、乳腺、肺和肝。除了抑制细胞增殖和迁移外,miR-379 还可以抑制上皮-间充质转化过程。该 miRNA 的异常表达暗示了杜氏肌营养不良症、脊髓损伤、糖尿病肾病、急性心肌梗死和卵巢早衰的发病机制。本综述旨在总结 miR-379 在肿瘤和非肿瘤疾病中的作用。